Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Phase-III-study-demonstrates-adjuvant-Tafinlar-Mekinist-reduced-the-risk-of-disease-25091799/?utm_source=whatsapp&utm_medium=social&utm_campaign=share